Keita Funakawa, COO and co-founder of Nanome, and Steve McCloskey, CEO and co-founder, delve into the groundbreaking world of virtual reality in scientific research. They share how Nanome's technology transforms molecular interactions, enhancing collaboration in drug discovery and biopharma. The conversation reveals their unique backgrounds in computer science and nanoengineering, their early VR experiences at UC San Diego, and the platform's innovative impact on chemistry education, promising to democratize science and revolutionize research practices.
